Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Eur J Cancer. 2021 Feb 16;146:125–134. doi: 10.1016/j.ejca.2020.12.031

Figure 1.

Figure 1.

High LAMC2 expression associates with worse prognosis in PDAC patients in the training and validation cohort. (A) The distribution of LAMC2 expression in PDAC patients. (B) Kaplan-Meier curves for OS between PDAC patients with high (pink) and low (blue) LAMC2 expression in the training cohort. (C) Comparison of LAMC2 expression levels in PDAC patients with or without recurrence. (D) Kaplan-Meier curves for RFS between PDAC patients with high (pink) and low (blue) LAMC2 expression in the training cohort. Kaplan-Meier curves for (E) OS and (F) RFS in the validation cohort. *, P<0.05.